Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Key Inclusion Criteria: * Must be 18 years of age and provide written informed consent and sign the HIPAA form * Must have history of allergic rhinitis * Must have positive response to Allergen BioCube Key Exclusion Criteria: * Must not have a significant illness such as moderate to severe allergic asthmatic reactions * Must not have compromised lung function * Must not use any disallowed medications * Must not have been in an investigational study in the last 30 days